Mufg Securities Americas Inc. Purchases New Holdings in Danaher Co. (NYSE:DHR)

Mufg Securities Americas Inc. acquired a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 9,489 shares of the conglomerate's stock, valued at approximately $2,178,000.

A number of other institutional investors have also recently modified their holdings of DHR. Malaga Cove Capital LLC raised its position in Danaher by 23.5% in the fourth quarter. Malaga Cove Capital LLC now owns 5,298 shares of the conglomerate's stock valued at $1,216,000 after purchasing an additional 1,007 shares during the period. NorthRock Partners LLC lifted its stake in Danaher by 129.7% in the fourth quarter. NorthRock Partners LLC now owns 8,323 shares of the conglomerate's stock valued at $1,910,000 after buying an additional 4,700 shares during the last quarter. Nuveen Asset Management LLC grew its holdings in shares of Danaher by 2.8% during the fourth quarter. Nuveen Asset Management LLC now owns 4,068,948 shares of the conglomerate's stock worth $934,027,000 after buying an additional 111,894 shares during the last quarter. Numerai GP LLC purchased a new position in shares of Danaher during the fourth quarter worth about $1,983,000. Finally, OMERS ADMINISTRATION Corp raised its position in Danaher by 74.3% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 50,202 shares of the conglomerate's stock worth $11,524,000 after acquiring an additional 21,397 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. JPMorgan Chase & Co. cut their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Guggenheim reiterated a "buy" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Finally, StockNews.com upgraded Danaher from a "hold" rating to a "buy" rating in a report on Monday, May 12th. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $264.40.

Insider Buying and Selling

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

DHR traded down $0.52 on Monday, hitting $195.59. 984,136 shares of the stock traded hands, compared to its average volume of 3,444,457. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $139.98 billion, a PE ratio of 37.04, a P/E/G ratio of 2.66 and a beta of 0.80. The business has a fifty day moving average price of $196.87 and a two-hundred day moving average price of $217.27.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. On average, research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's payout ratio is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.